Добірка наукової літератури з теми "Latent HIV"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Latent HIV".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Latent HIV"
Stout, Jason E., Yanjue Wu, Christine S. Ho, April C. Pettit, Pei-Jean Feng, Dolly J. Katz, Smita Ghosh, Thara Venkatappa, and Ruiyan Luo. "Evaluating latent tuberculosis infection diagnostics using latent class analysis." Thorax 73, no. 11 (July 7, 2018): 1062–70. http://dx.doi.org/10.1136/thoraxjnl-2018-211715.
Повний текст джерелаHarrison, Charlotte. "Waking up latent HIV." Nature Reviews Drug Discovery 11, no. 9 (August 31, 2012): 674. http://dx.doi.org/10.1038/nrd3833.
Повний текст джерелаCruz-Lorenzo, Emily, Nora-Guadalupe P. Ramirez, Jeon Lee, Sonali Pandhe, Lei Wang, Juan Hernandez-Doria, Adam M. Spivak, et al. "Host Cell Redox Alterations Promote Latent HIV-1 Reactivation through Atypical Transcription Factor Cooperativity." Viruses 14, no. 10 (October 18, 2022): 2288. http://dx.doi.org/10.3390/v14102288.
Повний текст джерелаCary, Daniele C., and B. Matija Peterlin. "Targeting the latent reservoir to achieve functional HIV cure." F1000Research 5 (May 26, 2016): 1009. http://dx.doi.org/10.12688/f1000research.8109.1.
Повний текст джерелаMayanja, Edison, Livingstone S. Luboobi, Juma Kasozi, and Rebecca N. Nsubuga. "Mathematical Modelling of HIV-HCV Coinfection Dynamics in Absence of Therapy." Computational and Mathematical Methods in Medicine 2020 (October 6, 2020): 1–27. http://dx.doi.org/10.1155/2020/2106570.
Повний текст джерелаJefferys, Stuart R., Samuel D. Burgos, Jackson J. Peterson, Sara R. Selitsky, Anne-Marie W. Turner, Lindsey I. James, Yi-Hsuan Tsai, et al. "Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors." PLOS Pathogens 17, no. 2 (February 26, 2021): e1009346. http://dx.doi.org/10.1371/journal.ppat.1009346.
Повний текст джерелаDestache, Christopher J. "HIV Latent Reservoir Cure Strategies." iScience Notes 1, no. 1 (October 15, 2016): 2. http://dx.doi.org/10.22580/2016/iscinote.2.
Повний текст джерелаDestache, Christopher J. "HIV Latent Reservoir Cure Strategies." iScience Notes 1, no. 1 (October 15, 2016): 1. http://dx.doi.org/10.22580/2016/iscinotej1.1.2.
Повний текст джерелаBlankson, Joel, Deborah Persaud, and Robert F. Siliciano. "Latent reservoirs for HIV-1." Current Opinion in Infectious Diseases 12, no. 1 (February 1999): 5–11. http://dx.doi.org/10.1097/00001432-199902000-00002.
Повний текст джерелаKoup, Richard A. "A new latent HIV reservoir." Nature Medicine 7, no. 4 (April 2001): 404–5. http://dx.doi.org/10.1038/86455.
Повний текст джерелаДисертації з теми "Latent HIV"
Andrews, Sophie Marie. "Adaptive immune evasion in clinically latent HIV infection." Thesis, University of Oxford, 2016. https://ora.ox.ac.uk/objects/uuid:b7416aab-d345-48df-9194-797c62d7db47.
Повний текст джерелаEsmail, Hanif. "How latent is 'latent' tuberculosis? : the radiographic, transcriptional and immunological characterisation of subclinical tuberculosis in HIV infected adults." Thesis, Imperial College London, 2014. http://hdl.handle.net/10044/1/30658.
Повний текст джерелаSILVA, NETO Francisco Bernardino da. "Teste tuberculínio no diagnóstico da infecção latente pelo Mycobacterium tuberculosis em pessoas vivendo com HIV/AIDS em um hospital de referência no Estado da Paraíba." Universidade Federal de Pernambuco, 2015. https://repositorio.ufpe.br/handle/123456789/17702.
Повний текст джерелаMade available in DSpace on 2016-08-18T14:35:26Z (GMT). No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) Dissertação_Bernardino_Versão_Final_13_04_2016VF_ATUAL (1).pdf: 1504145 bytes, checksum: 378eee47758feaa1664c834f3a789e0c (MD5) Previous issue date: 2015-08-20
O diagnóstico e o tratamento da infecção latente pelo Mycobacterium tuberculosis (ILTB) são indicados para grupos nos quais a prevalência da infecção latente é alta, em contactantes de casos novos de tuberculose (TB) e quando o risco de reativação é alto como em pessoas vivendo com HIV/AIDS (PVHA). Tanto o vírus da imunodeficiência humana (HIV) facilita a reativação da ILTB quanto o Mycobacterium tuberculosis contribui para a progressão da doença pelo HIV. O conhecimento acerca do diagnóstico e do tratamento da ILTB em PVHA torna-se fundamental visto que o Relatório Global de Controle da Tuberculose da Organização Mundial da Saúde (OMS) indica que as PVHA estão 26 a 31 vezes mais propensas a desenvolver TB ativa quando comparadas à população geral. Além disso, a taxa de letalidade da TB em PVHA é 3 vezes maior do que a observada na população geral. Apesar de suas limitações, o teste tuberculínico (TT) continua sendo a principal ferramenta de diagnóstico da ILTB, entretanto, isso não parece refletir no número de TT solicitados e realizados e, consequentemente, no número de tratamentos prescritos para ILTB. No Brasil, e em particular na Paraíba, os dados sobre a solicitação e realização do TT e acerca da prescrição do tratamento para ILTB são pouco conhecidos. Esse estudo objetivou verificar a frequência de solicitação e de realização (inoculação do derivado protéico purificado (PPD) e leitura) do TT, a frequência de TT reator e a frequência da prescrição do tratamento para ILTB e caracterizar as PVHA atendidas em serviço de referência em HIV/AIDS e TB no estado da Paraíba quanto a aspectos sociodemográficos e laboratoriais, no período de janeiro de 2009 a dezembro de 2013. Para obtenção dos dados, utilizou-se formulário padronizado, preenchido, retrospectivamente, a partir das informações contidas na primeira consulta registrada nos prontuários dos pacientes atendidos no período do estudo. Dos 3.191 pacientes incluídos na pesquisa, 2.303 (72,2%) tiveram o TT solicitado. Destes, 2.047 (89,0%) foram submetidos a realização do TT que compreendeu a inoculação do PPD e a leitura da induração. Dos 2.047 pacientes que tiveram o PPD inoculado e submetidos a leitura da induração, 90 (4,4%) pacientes tiveram o TT reator sendo o tratamento para ILTB prescrito para todos. Os resultados da pesquisa sugerem que há uma excelente adesão à solicitação do TT e à prescrição do tratamento para ILTB entre os profissionais médicos e baixa prevalência de ILTB no local do estudo. Outrossim, acessibilidade adequada para realização e boa compreensão por parte dos pacientes quanto a sua importância no contexto da atenção à saúde das PVHA garantiram a frequência elevada de realização do TT.
The diagnosis and treatment of latent infection with Mycobacterium tuberculosis (LIMTb) are given to groups in which the prevalence of latent infection is high, in contacts of new cases of tuberculosis (TB) and when the risk of reactivation is high as in people living with HIV/AIDS (PLHA). Both the human immunodeficiency virus (HIV) facilitates the reactivation of LIMTb as Mycobacterium tuberculosis contributes to the progression of HIV disease. The knowledge about the diagnosis and treatment for PLHA in LIMTb becomes critical as the Global Tuberculosis Control Report of the World Health Organization (WHO) indicates that PLHA are 26-31 times more likely to develop active TB compared the general population. In addition, the TB mortality rate PLHA is 3 times higher than that observed in the general population. Despite its limitations, the tuberculin skin test (TST) remains the primary diagnostic tool LIMTb, however, this does not reflect the number of TST ordered and carried out and, consequently, the number of prescription treatments for LIMTb. In Brazil, particularly in Paraiba, data on the application and realization of TST and for prescribing treatment for LIMTb are little known. Thus faces, this study aimed to verify the request frequency and achievement (inoculation of purified protein derivative (PPD) and reading of induration) of TST, the TST frequency of reactor and the frequency of prescription treatment for LIMTb and characterize the PLHA met in reference service on HIV/AIDS and TB in the state of Paraiba as the sociodemographic and laboratory aspects, from January 2009 to December 2013. To obtain the data, we used standardized form filled out retrospectively from information contained on the first visit recorded in the medical records of patients seen during the study period. Of the 3,191 patients included in the study, 2,303 (72.2%) had the TST requested. Of these, 2,047 (89.0%) underwent TST understood that inoculation of the PPD and the reading of induration. Of the 2,047 patients who had the PPD inoculated and subjected to reading of induration, 90 (4.4%) patients had TST reactor being treating LIMTb prescribed for everyone. The survey results suggest there is excellent adhesion to the request of the TST and prescription treatment for LIMTb among medical professionals and low prevalence of LIMTb in the study site. Likewise sufficient access for achievement and good understanding by patients and their importance in the context of attention to health of PLHA ensured the high frequency of TST realization.
Hiener, Bonnie. "Genetic Characterisation of Persistent HIV-1 in Naïve and Memory CD4+ T-cells from Effectively Treated Individuals." Thesis, The University of Sydney, 2022. https://hdl.handle.net/2123/29533.
Повний текст джерелаAntunes, Aline Araújo. "Vigilância da Tuberculose Latente nas pessoas que vivem com HIV/aids em Ribeirão Preto - SP, 2012 e 2013." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/22/22133/tde-15022016-161844/.
Повний текст джерелаTB is the main opportunistic infection to affect people living with HIV/AIDS (PLWHA), and TB/HIV coinfection is a major challenge for health systems. The study aimed to describe the monitoring of latent TB in PLWHA followed by HIV/AIDS Specialized Health Services Specialized (SHS) of Ribeirão Preto-SP, in the years 2012 and 2013. It was an epidemiological descriptive study. Were included 33 individuals who developed diagnosis of latent tuberculosis in 2012 and 2013, reported in the System Information \"TB chemoprophylaxis,\" and living with HIV/AIDS, followed by the five SHS municipal public health network of Ribeirão Preto-SP. For data collection, it was initially conducted a survey of PLWHA diagnosed with latent tuberculosis, from the number of individuals registered in the information system (IS) \"TB chemoprophylaxis.\" After, it was used a structured questionnaire containing 30 questions which were considered the following sections: I - Socio-demographic data; II - Data on the clinical profile of PLWHA - at diagnosis of latent TB; III - Data on the control of TB in PLWHA; IV Data on the situation, monitoring strategies and the outcome of latent TB in PLWHA. The study was developed from secondary sources of information: Information System \"TB chemoprophylaxis\"; Health Record; Computerized Hygia-Web system and Notifiable Diseases Information System (SINAN). As a complement, with the support of a particular script we interviewed the key actor - Municipal Program Coordinator for Tuberculosis Control and STD/AIDS - in order to characterize the scenario focusing on the description of the actions about prevention and control of TB in PLWHA. Data analysis was performed using descriptive statistics technique. Of the 355 cases identified in the IS chemoprophylaxis TB, 135 were reported in 2012 and 220 in 2013, with 44 occurrences involving PLWHA in the follow-up in the municipal public health system, of which 21 (47.7%) belonged to the SHS \"C\". Eleven cases were excluded due to non-location clinical records and errors in the classification of individuals who did not have the diagnosis of HIV/AIDS. Of the 33 PLWHA considered in the final study sample, there was a predominance of males (54.5%), aged 31-60 years (72.7%), economically active and married/common-law marriage (36.4%). Regarding the clinical profile, 75.8% had AIDS as a diagnostic situation, made use of ART, but only 30.3% had monthly removal of records of such drugs. The protective cell count (CD4 +) and viral load indicated stabilization of HIV/AIDS in most subjects. As for the control and outcome of QT, the majority (93.9%) of patients held in the self-administered treatment modality, with 22 (66.7%) completed the treatment but there was a dropout rate of 18.1 %. TB being the main opportunistic disease to affect and be responsible for more deaths associated with PLWHA, it is essential to implement strategies that enhance the surveillance of latent TB in PLWHA contributing as a key measure to control active disease. Surveillance data contribute to the planning and improvement of actions and interventions provided. So challenges are launched with regard to the integration of both programs forward the importance of surveillance and management of diseases in the context of public policy
Ranganath, Nischal. "Oncolytic Viruses as a Potential Approach to Eliminate Cells That Constitute the Latent HIV Reservoir." Thesis, Université d'Ottawa / University of Ottawa, 2018. http://hdl.handle.net/10393/37355.
Повний текст джерелаFong, Linda Ellen. "Data-Driven Analysis of Phospho-Signaling Network Responses Enables Latent HIV Infected T Cell Targeting." Thesis, Yale University, 2018. http://pqdtopen.proquest.com/#viewpdf?dispub=10957324.
Повний текст джерелаViral latency remains the most significant obstacle to HIV eradication. Current clinical strategies aim to purge the latent CD4+ T cell reservoir by activating viral expression, but are undercut by the inability to clear the latent reservoir. We first evaluated co-drugging criteria in a quantitative manner to optimize viral expression. However, this approach faces many challenges; and thus, we proposed to identify and target dysregulated signaling pathways in latent HIV-infected cells to promote cell death as a novel approach for eradication. To identify how HIV latency and reactivation alter signal transduction pathways regulating cell death, we explored the acute signaling response of latent HIV-infected CD4+ T cells across in vitro human latency models using systems-level analyses. We measured phosphorylation of five signaling proteins (AKT, IKBa, ERK, p38, and JNK) after stimulation with T-cell activating agents or latency reversing agents in infected cells and uninfected cells. Using these phosphorylation signatures, we built data-driven statistical models that successfully classified infected and uninfected cells, demonstrating that latent infection alters signaling at a systems level. We further identified that the stress kinase pathways p38 and JNK exhibited elevated signaling in latently infected cells and could be targeted to specifically increase cell death, independent of HIV reactivation.
To work out the mechanisms by which latent and reactivating HIV alters cell death regulation, we further examined signaling of 31 proteins in single cells over 48 hours using mass cytometry. Mass cytometry provides measurements at single-cell resolution, enabling us to separate responses in cells with latent versus reactivating HIV based on viral expression. We used conditional density-based analysis of the single-cell data to quantify the strength of signaling activity along different pathways. We discovered that latent and HIV-expressing cells are sensitized to apoptotic cell death via activation of p38-p53 signaling and inhibition of AKT/mTOR signaling. We identified a novel interaction in infected cells, in which increased p38 signaling activates the pro-death activity of the protein BAD, leading to increased apoptosis. Finally, we show in vitro that p38 and AKT/mTOR pathways can be simultaneously targeted to deplete the latent reservoir by preferentially killing latently infected cells without viral activation. Overall, we demonstrate that targeting altered phosphorylation signatures of latent HIV-infected cells provides a novel and effective strategy for latent HIV eradication.
Kunze, Christine [Verfasser], and Ruth [Akademischer Betreuer] Brack-Werner. "Strategien zur Inhibierung der HIV-Reaktiverung in latent infizierten Astrozyten / Christine Kunze ; Betreuer: Ruth Brack-Werner." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2017. http://d-nb.info/1150159189/34.
Повний текст джерелаValencia, Celina I., and Celina I. Valencia. "Modeling social factors of HIV risk in Mexico." Diss., The University of Arizona, 2017. http://hdl.handle.net/10150/625554.
Повний текст джерелаO'Loughlin, Christina. "Evaluation of measurement quality in the assessment of health related issues using structural equation modelling techniques." Thesis, University of Ulster, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.342424.
Повний текст джерелаКниги з теми "Latent HIV"
Laure, Aurelian, ed. Herpesviruses, the immune system, and AIDS. Boston: Kluwer Academic Publishers, 1990.
Знайти повний текст джерелаSilvestri, Guido, and Mathias Lichterfeld, eds. HIV-1 Latency. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-030-02816-9.
Повний текст джерелаCatullus and his world: A reappraisal. Cambridge: Cambridge University Press, 1985.
Знайти повний текст джерелаSouster, Raymond. Raymond Souster reads from his latest book, Jubilee of death, the raid on Dieppe. [Toronto?]: Designed and handprinted by Frederick Turner, 1985.
Знайти повний текст джерелаCicero, Marcus Tullius. Cicero's letters to his friends. Atlanta, Ga: Scholars Press, 1988.
Знайти повний текст джерелаForstinger, Christin M. Finanzwirtschaftliche Sanierungsmassnahmen von der latenten beherrschbaren Krise bis hin zur Insolvenz. Linz: Universitätsverlag R. Trauner, 1999.
Знайти повний текст джерелаAnthony. Seek first his kingdom. [Padova: Editrice Messagero di S. Antoni, 1988.
Знайти повний текст джерелаLivio, Poloniato, and Jarmak Claude, eds. Seek first his kingdom. Padova]: [Editrice Messagero di S. Antoni], 1988.
Знайти повний текст джерелаManilius and his intellectual background. Oxford: Oxford University Press, 2009.
Знайти повний текст джерелаVirgil: His life and times. New York: St. Martin's Press, 1999.
Знайти повний текст джерелаЧастини книг з теми "Latent HIV"
Buckheit, Robert W., and Joel N. Blankson. "Immunology of Latent HIV Infection." In Encyclopedia of AIDS, 1–7. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-9610-6_190-1.
Повний текст джерелаBuckheit, Robert W., and Joel N. Blankson. "Immunology of Latent HIV Infection." In Encyclopedia of AIDS, 1077–83. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7101-5_190.
Повний текст джерелаConrad, Ryan J., Daniela Boehm, and Melanie Ott. "Activating Latent HIV by Inhibiting Bromodomain Proteins." In Histone Recognition, 225–41. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-18102-8_11.
Повний текст джерелаChoudhary, Shailesh K. "Latent HIV-1 Infection of Resting CD4+ T cells: Testing Approaches to Overcome HIV Latency." In Humanized Mice for HIV Research, 289–303. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1655-9_24.
Повний текст джерелаPettit, April C., and Timothy R. Sterling. "Recent Advances in the Treatment of Latent Tuberculosis Infection Among Adults Living with HIV Infection." In HIV and Tuberculosis, 161–79. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-29108-2_8.
Повний текст джерелаGuihenneuc-Jouyaux, Chantal, Sylvia Richardson, and Virginie Lasserre. "Convergence Assessment in Latent Variable Models: Application to the Longitudinal Modelling of a Marker of HIV Progression." In Discretization and MCMC Convergence Assessment, 147–60. New York, NY: Springer New York, 1998. http://dx.doi.org/10.1007/978-1-4612-1716-9_7.
Повний текст джерелаLaird, Gregory M., Daniel I. S. Rosenbloom, Jun Lai, Robert F. Siliciano, and Janet D. Siliciano. "Measuring the Frequency of Latent HIV-1 in Resting CD4+ T Cells Using a Limiting Dilution Coculture Assay." In Methods in Molecular Biology, 239–53. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3046-3_16.
Повний текст джерелаJack, John, Andrei Păun, and Alfonso Rodríguez-Patón. "Effects of HIV-1 Proteins on the Fas-Mediated Apoptotic Signaling Cascade: A Computational Study of Latent CD4+ T Cell Activation." In Membrane Computing, 246–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-95885-7_18.
Повний текст джерелаHill, Alison L. "Mathematical Models of HIV Latency." In Current Topics in Microbiology and Immunology, 131–56. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/82_2017_77.
Повний текст джерелаKhoury, Georges, Gilles Darcis, Michelle Y. Lee, Sophie Bouchat, Benoit Van Driessche, Damian F. J. Purcell, and Carine Van Lint. "The Molecular Biology of HIV Latency." In HIV Vaccines and Cure, 187–212. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-0484-2_8.
Повний текст джерелаТези доповідей конференцій з теми "Latent HIV"
Gray-Owen, Scott, and Furkan Guvenc. "P689 Turning gonorrhea against HIV: latent HIV ‘shock-and-kill’ using a gonococcal-derived metabolite." In Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/sextrans-2019-sti.755.
Повний текст джерелаShutt, Deborah, and Stephen Pankavich. "An in-host model of HIV incorporating latent infection and viral mutation." In The 10th AIMS Conference on Dynamical Systems, Differential Equations and Applications (Madrid, Spain). American Institute of Mathematical Sciences, 2015. http://dx.doi.org/10.3934/proc.2015.0913.
Повний текст джерелаvan Zyl-Smit, Richard N., William N. Rom, Richard Meldau, Greg Calligaro, Gregory Symons, Jessica Phillips, Eric D. Bateman, Michael Weiden, Keertan Dheda, and Rodney Dawson. "Immunodiagnosis Of Latent TB In HIV-Infected Persons In A High Burden Setting." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4885.
Повний текст джерелаJafaruddin, Sutimin, and Ariyanto. "A model dynamic for effect latent population to co-epidemic of HIV-TB." In SYMPOSIUM ON BIOMATHEMATICS (SYMOMATH 2013). AIP Publishing LLC, 2014. http://dx.doi.org/10.1063/1.4866534.
Повний текст джерелаZifodya, J. S., S. M. LaCourse, T. Temu, E. Attia, S. Masyuko, G. Nyale, J. Nyabiage, et al. "Latent TB Infection and QuantiFERON-TB Gold Plus in HIV-Infected and Uninfected Kenyan Adults." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2694.
Повний текст джерелаKirkham, Deborah. "O02 Screening for latent tuberculosis in a large urban HIV positive population – pilot reveals 11.6% positivity rate." In BASHH 2022 Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/sextrans-bashh-2022.2.
Повний текст джерелаVan Zyl-Smit, Richard N., William Rom, Richard Meldau, Gregory Calligaro, Gregory Symons, Michael Weiden, Eric D. Bateman, Keertan U. J. Dheda, and Rodney Dawson. "Changes In Immunodiagnostic Test Results For Latent TB In HIV-Infected Persons In A High Burden Setting." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4723.
Повний текст джерелаReviono, Reviono, and Harsini Harsini. "Validity and reliability of tst and T-SPOT examination to detect latent tb infection in HIV infected patients." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa3048.
Повний текст джерелаGray, Jacob M., Randall Reves, and Robert Belknap. "Improvement In Latent Tuberculosis Testing Of HIV Patients After Switching From The Tuberculin Skin Test To Quantiferon-TB Gold-In-Tube." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1197.
Повний текст джерелаLevine, P. H. "ACQUIRED IMMUNODEFICIENCY SYNDROME, HUMAN IMMUNODEFICIENCY VIRUS AND HEMOPHILIA." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644752.
Повний текст джерелаЗвіти організацій з теми "Latent HIV"
Ratner, Lee. Development of an RNA Assay to Access HIV-1 Latency. Fort Belvoir, VA: Defense Technical Information Center, April 1991. http://dx.doi.org/10.21236/ada251728.
Повний текст джерелаRatner, Lee. Development of an RNA Assay to Assess HIV I Latency. Fort Belvoir, VA: Defense Technical Information Center, January 1993. http://dx.doi.org/10.21236/ada269479.
Повний текст джерелаBongaarts, John. Late marriage and the HIV epidemic in sub-Saharan Africa. Population Council, 2006. http://dx.doi.org/10.31899/pgy2.1039.
Повний текст джерелаvan Dam, Johannes, and Marie Christine Anastasi. Male circumcision and HIV prevention: Directions for future research. Population Council, 2000. http://dx.doi.org/10.31899/hiv2000.1000.
Повний текст джерелаBruce, Judith, and Shelley Clark. The implications of early marriage for HIV/AIDS policy. Population Council, 2004. http://dx.doi.org/10.31899/pgy22.1000.
Повний текст джерелаCaston, Will. Latino Men Managing HIV: An Appraisal Analysis of Intersubjective Relations in the Discourse of Five Research Interviews. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.2068.
Повний текст джерелаBecker, Julie, Elizabeth Leitman, and Mahmoud Fathalla. Introducing sexuality within family planning: The experience of three HIV/STD prevention projects from Latin America and the Caribbean. Population Council, 1997. http://dx.doi.org/10.31899/pgy4.1007.
Повний текст джерелаTyshchenko, Yelyzaveta Yu, та Andrii M. Striuk. Актуальність розробки моделі адаптивного навчання. [б. в.], грудень 2018. http://dx.doi.org/10.31812/123456789/2889.
Повний текст джерелаCox, Jeremy. The unheard voice and the unseen shadow. Norges Musikkhøgskole, August 2018. http://dx.doi.org/10.22501/nmh-ar.621671.
Повний текст джерелаAcevedo, Ivonne, Francesca Castellani, Giulia Lotti, and Miguel Székely. Labor Market Gender Gaps in the Time of COVID-19 in Latin America and the Caribbean. Inter-American Development Bank, December 2022. http://dx.doi.org/10.18235/0004580.
Повний текст джерела